Intuitive Surgical, Inc. $ISRG Shares Purchased by Diversified Enterprises LLC

Diversified Enterprises LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 96.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 2,746 shares of the medical equipment provider’s stock after purchasing an additional 1,349 shares during the quarter. Diversified Enterprises LLC’s holdings in Intuitive Surgical were worth $1,555,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ISRG. Rakuten Investment Management Inc. acquired a new position in Intuitive Surgical during the third quarter worth $388,436,000. Assenagon Asset Management S.A. boosted its stake in Intuitive Surgical by 106.6% during the fourth quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock worth $868,667,000 after buying an additional 791,516 shares during the last quarter. Amundi boosted its stake in Intuitive Surgical by 29.7% during the third quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock worth $1,451,362,000 after buying an additional 739,444 shares during the last quarter. Sands Capital Management LLC boosted its stake in Intuitive Surgical by 77.0% during the third quarter. Sands Capital Management LLC now owns 1,341,109 shares of the medical equipment provider’s stock worth $599,784,000 after buying an additional 583,539 shares during the last quarter. Finally, Victory Capital Management Inc. boosted its stake in Intuitive Surgical by 41.3% during the third quarter. Victory Capital Management Inc. now owns 1,941,310 shares of the medical equipment provider’s stock worth $868,212,000 after buying an additional 567,483 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 beat and raised outlook — ISRG reported stronger‑than‑expected Q1 revenue and EPS, raised full‑year procedure guidance and cited broad procedure adoption; that drove the initial rally after the print. Read More.
• Positive Sentiment: da Vinci 5 and innovation-led revenue — Analysts and coverage note revenues are outpacing procedures as da Vinci 5 placements and service/consumable pricing power shift growth toward innovation and value-based revenue. Read More.
• Positive Sentiment: Analysts reaffirm bullish views — several firms reiterated buy/overweight ratings and raised forecasts after the quarter, saying procedure momentum and platform adoption support longer‑term upside. Read More.
• Neutral Sentiment: Market commentary highlights long‑term case — investment pieces argue ISRG remains a secular winner in robotic surgery despite near‑term volatility; these are thematic views rather than short‑term catalysts. Read More.
• Negative Sentiment: Mixed/trimmed price targets — several banks trimmed price targets post‑earnings (some materially) even while keeping buy/overweight ratings; the patchwork of cuts likely contributed to selling pressure. Read More.
• Negative Sentiment: Cybersecurity note — the company disclosed a contained cyber incident and is remediating; while management calls it contained, such disclosures can increase near‑term uncertainty for investors. Read More.
• Negative Sentiment: Guidance conservatism / profit‑taking — some coverage points out the company raised guidance modestly relative to the beat, which may signal conservative assumptions and prompted traders to book gains after the initial surge. Read More.

Intuitive Surgical Trading Down 1.0%

ISRG stock opened at $478.82 on Friday. The company has a market capitalization of $170.04 billion, a PE ratio of 58.04, a P/E/G ratio of 3.78 and a beta of 1.68. Intuitive Surgical, Inc. has a 12-month low of $427.84 and a 12-month high of $603.88. The business’s fifty day moving average price is $477.54 and its 200 day moving average price is $515.16.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.08 by $0.42. The firm had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company’s quarterly revenue was up 23.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.81 EPS. Research analysts predict that Intuitive Surgical, Inc. will post 8.16 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 645 shares of the business’s stock in a transaction on Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the sale, the senior vice president owned 1,613 shares in the company, valued at approximately $782,321.13. The trade was a 28.57% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Fredrik Widman sold 133 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the sale, the vice president owned 660 shares in the company, valued at $326,673.60. This represents a 16.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 32,943 shares of company stock worth $17,279,568 over the last quarter. 0.60% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent research reports. TD Cowen lowered their price objective on Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating on the stock in a research note on Wednesday. JPMorgan Chase & Co. decreased their price target on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a research note on Wednesday. Piper Sandler reduced their price objective on shares of Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating on the stock in a report on Wednesday. Jefferies Financial Group reduced their price objective on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a report on Wednesday. Finally, Truist Financial reduced their price objective on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating on the stock in a report on Wednesday, April 15th. Eighteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $581.91.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.